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A B S T R A C T
Adenosine is a potent neuromodulator in the central nervous system (CNS). The functional deterioration
of adenosine A1 receptors in the CNS was reported to cause a failure of termination of seizures and to a
lower seizure threshold of hyperthermia-induced seizures (HS) in childhood rats, which may contribute
to adenosine-related convulsive disorders such as theophylline-associated seizures in childhood
patients. In contrast to the inhibitory effect of adenosine A1 receptors, the function of adenosine A2A
receptors remains controversial. To clarify the function of adenosine A2A receptors in childhood
convulsive disorders associated to hyperthermia, we investigated the in vivo interaction between
adenosine A2A receptors and their ligands in HS in childhood rats. Adenosine selective A2A receptor
ligands were injected intraperitoneally before HS. We measured brain temperature at the onset of
seizures and the mortality rate after HS. We found that brain temperature at seizure onset was
signiﬁcantly higher in the A2A receptor antagonist group compared with that in the control group
(p < 0.05), and there was no signiﬁcant difference in mortality among the groups. In contrast, brain
temperature at seizure onset was signiﬁcantly lower in the A2A receptor agonist group compared with
that in the control group (p < 0.05), and mortality was signiﬁcantly higher in the A2A agonist group
compared with that in the control group (p < 0.001). The activation of the adenosine A2A receptor might
enhance seizures associated to hyperthermia in the childhood human brain, and be involved in the
pathogenesis of sudden unexpected death in epilepsy (SUDEP) in childhood patients with convulsive
disorders.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
Seizure
journal homepage: www.e lsev ier .com/ locate /yse iz1. Introduction
Inhibitory neuro-modulation by adenosine has been reported to
be largely mediated by activation of selective adenosine A1
receptors that are highly distributed in the cerebral cortex.
Adenosine is a powerful neuromodulator in the central nervous
system (CNS), exerting its functions via activation of the high-
afﬁnity adenosine A1 or A2A receptors, and low-afﬁnity A2B or A3
receptors.1,2 Our previous study demonstrated that the functional
deterioration of adenosine A1 receptors in the CNS contributes to
failure of termination of seizures and to a lower seizure threshold
of hyperthermia-induced seizures (HS) in childhood rats, which
may cause adenosine-related convulsive disorders such as
theophylline-associated seizures (TAS) in childhood patients.3
Theophylline is a nonselective adenosine receptor antagonist, and
fever and a young age have been reported to be risk factors for* Corresponding author. Tel.: +81 89 960 5320; fax: +81 89 960 5941.
E-mail addresses: fukumits@m.ehime-u.ac.jp, fukudami@dokidoki.ne.jp
(M. Fukuda).
1059-1311/$ – see front matter  2010 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2010.11.012TAS.4,5 We have thus used childhood rodents with HS as a model
for TAS.
In contrast to the general inhibitory role of A1 receptors, both
inhibitory as well as excitatory responses to pathogens in
convulsive disorders are mediated via A2A receptors.
6,7 To clarify
the role of selective adenosine A2A receptors in childhood
convulsive disorders associated to hyperthermia, we investigated
the in vivo interaction between the adenosine A2A receptor and its
ligands in HS using childhood rats.
2. Materials and methods
2.1. Animals
Male Lewis rats (20–21 days old) were kept with their mothers
under a standard schedule of a 12 h light–12 h dark cycle,
controlled temperature, and unlimited food and water in standard
animal facilities during the entire experimental period. All
experimental procedures were performed according to the guide-
lines from theMinistry of Education of Japan andwere approved byvier Ltd. All rights reserved.
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Fig. 1. EEG ﬁndings in childhood rats. Sustained irregular 6–8 Hz activity was
recorded prior to warming (baseline). Spikes and spike-wave bursts were induced
several minutes after warming with moist warm air (seizures).
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2.2. Preparation for recording electroencephalography and brain
temperature
A stereotaxic holder (Narishige Co., Ltd., Tokyo, Japan) was used
to ﬁx the head in place. Two holes were made in the skull over the
right frontal and occipital cortex for placement of silver
electroencephalography (EEG) electrodes and plastic receptacles
(Unique Medical Co., Ltd., Tokyo, Japan). Another hole was made
over the left central cortex for placement of a needle brain
temperature thermometer (Unique Medical Co.). These manipula-
tions were performed under anesthesia using an intraperitoneal
injection of 30 mg/kg pentobarbital sodium (Dainippon Pharma
Co., Osaka, Japan).
2.3. Drug application and induction of hyperthermia-induced seizures
The selective adenosine A2A receptor antagonist 5-amino-7-(2-
phenylethyl)-2-(2-furyl)-pyrazolo-[4,3-c]1,2,4-triazolo[1,5-c]py-
rimidine (SCH58261) (Cosmo Bio Co., LTD. Tokyo, Japan) was used
for experiments. Rats were divided into three groups 72 h after
surgery as follows: SCH58261with a dose of 0.5 and 5 mg/kg, and a
control group (n = 9 in each group). SCH58261 was dissolved in
20% DMSO in distilled water. A total of 0.25 ml of SCH58261 or 20%
DMSO for controls was given intraperitoneally prior to HS. Thirty
minutes after administration of SCH58261 or DMSO, each rat was
placed in a special plastic cage. HSwere induced bymoist warm air
(45–50 8C) and they were monitored using EEG. Brain temperature
was measured at the onset of seizures on the EEG as an index of
seizure threshold and the seizure duration time was measured as
an index of seizure termination. Additionally, we observed each rat
for 24 h after HS, and calculated mortality rates in each group. We
also carried out a second experiment using 50-(N-cyclopropyl)-
carboxamido-adenosine (CPCA) (Sigma–Aldrich Co., St. Louis,
USA), which is a selective adenosine A2A receptor agonist. Rats
were divided into two groups 72 h after surgery as follows: CPCA
with a dose of 2 mg/kg, and a control group (n = 12 in each group).
CPCA was dissolved in 10% polyethylene glycol (PEG) in saline. A
total volume of 0.2 ml CPCA or 10% PEG for controls was given
intraperitoneally 15 min prior to HS. Brain temperatures at seizure
onset and the seizure durations were also measured. Themortality
in each groupwas conﬁrmed after HS. The timing of administration
of adenosine ligands was based on previous studies.6,8
2.4. Statistics
One-way analysis of variance followed by Scheffe’s multiple
comparisons test and unpaired t-tests were used for statistical
analysis in this study. Fisher’s exact probability test was performed
to analyze differences in mortality rate. A p-value of <0.05 was
considered to be signiﬁcant.
3. Results
Stereotypical seizures were induced in all rats by hyperthermia.
During a typical seizure, all movements abruptly stopped, and the
rat displayed a tonic posture, facial clonus, and generalized clonic
movement. Prior to HS, background EEG activity consisted of an
irregular theta rhythm. Continuous spikes and spike-wave bursts,
which are consistent with clinical seizures, were observed (Fig. 1).
Brain temperatures at seizure onset and seizure durations were
compared between rats given 0.5 mg/kg and 5 mg/kg of SCH58261
and the control group (Fig. 2A). Brain temperature at seizure onset
was signiﬁcantly higher in the 5 mg/kg SCH58261 group comparedwith that in controls (p < 0.05). However, there was no signiﬁcant
difference in seizure duration among the groups. There was no
signiﬁcant difference in the mortality rate among the groups
(Fig. 2B).
The effect of a selective A2A receptor agonist on HS is shown in
Fig. 3. Brain temperature at seizure onsetwas signiﬁcantly lower in
the 2 mg/kg CPCA group compared with that in controls (p < 0.05),
however, there was no signiﬁcant difference in seizure duration
among the groups. And the mortality rate was signiﬁcantly higher
in the 2 mg/kg CPCA group comparedwith that in the control group
(p < 0.001). Nine of ten deceased rats died in the ﬁrst few minutes
after HS.
4. Discussion
The present study demonstrated that the selective A2A
antagonist SCH58261 signiﬁcantly elevated the threshold temper-
ature for the initiation of HS in childhood rats in a dose-dependent
manner, but did not inﬂuence the seizure duration and mortality.
And the selective A2A receptor agonist CPCA signiﬁcantly lowered
the threshold temperature and enhanced the mortality rate after
HS. These data indicate that adenosine A2A receptor activation has
proconvulsive characteristics in HS in vivo.
Inhibitory neuro-modulation by adenosine is largely mediated
by activation of A1 receptors that are highly distributed in the
cerebral cortex, cerebellum, and hippocampus. The highest
expression of A2A receptors is found in the striatum, nucleus
accumbens and tuberculum olfactorium, but it has also been
detected in the cortex and hippocampus, albeit at much lower
densities.9 Contrary to the general inhibitory role of A1 receptors,
the function of A2A receptors remains controversial. The adenosine
[()TD$FIG]
Fig. 2. The effect of a selective adenosine A2A receptor antagonist on brain temperature at seizure initiation, seizure duration andmortality rate. (A) Threshold temperature for
the induction of seizures and the duration of seizures. Each histogram shows the mean  SE (n = 9 in each group). The brain temperature of the SCH58261 5 mg/kg, 0.5 mg/kg,
and control groups were 43.0  0.1 8C (mean  SE), 42.6  0.1, and 42.5  0.1. The brain temperature of the SCH58261 5 mg/kg group was signiﬁcantly higher than that in the
control group. The seizure duration of the SCH58261 5 mg/kg, 0.5 mg/kg, and control groups were 41  3 s, 42  4, and 47  6, with no signiﬁcant differences. (B) Mortality rate.
There were no signiﬁcant differences in mortality rate among the groups.
[TD$INLINE] indicates p < 0.05 compared with controls.
SCH58261: 5-amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo-[4,3-c]1,2,4-triazolo[1,5-c]-pyrimidine.
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0-N-ethylcarboxamido-adeno-
sine (2-HE-NECA) and 2-(4-(2-carboxyethyl)-phenylamino)-50-N-
ethylcarbox-amidoadenosine (CGS 21680), suppress seizures in
the audiogenic seizure-sensible DBA-2 mice model of generalized
reﬂex epilepsy.6 CPCA also suppresses seizure activity in the GEPR-
9 ratmodel of generalized brainstem epilepsy.8 In contrast to these
data, CGS21680 has a proconvulsive effect on piriform cortex
kindled seizures.7,10 Using adenosine A2A receptor knock out mice,
adenosine A2A receptor activation has been reported to exacerbate
cortex and limbic seizures but not brainstem seizures.11,12 The
function of A2A receptors might depend on the brain region where
they are located, which could play a role in the pathogenesis of
convulsive disorders. For example, the activation of A2A receptors
enhances seizures originating from the brain cortex, but inhibits
seizures from the brainstem. The present study suggested that the
cortex might be a more important region than the brainstem with
regard to the pathology of HS in the childhood brain. In addition,
we have previously shown that excessive levels of CNS adenosine
induced by an adenosine kinase (ADK) inhibitor suppress HS in
juvenile rats.3 Therefore, the adenosine A1 receptor appears to have
predominantly inhibitory effects compared with weak excitatory
function by activation of A2A receptors in our rodent model, and it
seems very possible that this weak effect of A2A antagonist make
the elevation of the threshold temperature dose-related.
Adenosine is also likely to contribute to seizure termination.13
but adenosine A2A receptor activation showed no signiﬁcant effect
on seizure termination in the present study. A previous reportdemonstrated that activation of the A1 receptor terminates
ongoing status epileptics.14 and blockage of the A1 receptor
contributes to failure of seizure termination.3 A2A receptor
function might play no role in the termination of convulsive
disorders, which is in contrast to the A1 receptor.
In this study, A2A receptor agonists signiﬁcantly enhanced
mortality after HS in childhood rats. Using a mouse model for
sudden unexpected death in epilepsy (SUDEP) with inhibitors of
the major adenosine-removing enzyme adenosine deaminase and
ADK, it was found that excessive activation of adenosine after
seizures, which induce overstimulation of adenosine receptors in
the brainstem, might trigger prolonged central apnea and
suppression of cardiac function.15 Central activation of A2A
receptors have been reported to be inhibit phrenic activity,
decrease blood pressure and tachycardia, and exaggerate apnea by
superior laryngeal nerve stimulation.16 In our previous study using
juvenile rats, administration of an adenosine A1 receptor agonist in
the TAS model did not increase mortality rate (data is not show).
Therefore, inadequate over-stimulation of the A2A receptor is the
likely cause of death after HS in our model. There have been no
studies that have shown a pathological relationship between
selective adenosine A2A receptor function and SUDEP. The
combination of A2A receptor antagonists with an ADK inhibitor,
which is used as a treatment for convulsive disorders,17,18might be
a safe therapeutic intervention. However, a limitation of this study
is that the model used is not a model of chronic epilepsy. The
mechanism of death in the setting of epilepsy might potentially be
[()TD$FIG]
Fig. 3. The effect of a selective adenosine A2A receptor agonist on brain temperature at seizure initiation, seizure duration andmortality rate. (A) Threshold temperature for the
induction of seizures and during seizures. Each histogram shows the mean  SE (n = 12 in each group). The brain temperatures of the CPCA 2 mg/kg group, 42.2  0.2 8C
(mean  SE), was signiﬁcantly higher than that in the control group, 42.6  0.1. The seizure duration of the CPCA 2 mg/kg and control groups were 40  4 s and 45  5, with no
signiﬁcant differences. (B) Mortality rate. The mortality rate of rats given CPCA 2 mg/kg, 83%, was signiﬁcantly higher than that in the control group, 8%.
[TD$INLINE] indicates p < 0.05, and [TD$INLINE] indicates p < 0.001 compared with controls.
CPCA: 50-(N-cyclopropyl)-carboxamido-adenosine.
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acute symptomatic seizure.
5. Conclusions
In summary, activation of the adenosine A2A receptor might
lower the seizure threshold and initiate seizures in the childhood
convulsive disorders associated to hyperthemia, and might also be
involved in the pathogenesis of SUDEP in children with convulsive
disorders.
Acknowledgment
This research was supported by a Research Promotion Award of
Ehime University.
References
1. Etherington LV, Frenguelli BG. Endogenous adenosine modulates epileptiform
activity in rat hippocampus in a receptor subtype-dependent manner. European
Journal of Neuroscience 2005;19:2539–50.
2. Fredholm BB, Chen JF, Cunha RA, Svenningsson P, Vaugeois JM. Adenosine and
brain function. Intational Review of Neurobiology 2005;63:191–270.
3. Fukuda M, Suzuki Y, Hino H, Kazuyo K, Morimoto T, Ishii E. Adenosine A1
receptor blockage mediates theophylline-associated seizures. Epilepsia
2010;51:483–7.
4. Miura T, Kimura K. Theophylline-induced convulsions in childrenwith epilepsy.
Pediatrics 2000;105:920.5. Korematsu S, Miyahara H, Nagakura T, Suenobu S, Izumi T. Theophylline-
associated seizures and their clinical characterizations. Pediatrics International
2008;50:95–8.
6. De Sarro G. Effects of adenosine receptor agonists and antagonists on audio-
genic seizure-sensible DBA/2 mice. Europian Journal of Pharmacology
1999;371:137–45.
7. Hosseinmardi N, Mirnajaﬁ-Zadeh J, Fathollahi Y, Shahabi P. The role of adeno-
sine A1 and A2A receptors of entorhinal cortex on piriform cortex kindled
seizures in rats. Pharmacological Research 2007;56:110–7.
8. Huber A, Gu¨ttinger M, Mo¨hler H, Boison D. Seizure suppression by adenosine
A2A receptor activation in a rat model of audiogenic brainstem epilepsy.
Neuroscience Letter 2002;329:289–92.
9. Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, Linden J. International union
of Pharmacology. XXV. Nomenclature and classiﬁcation of adenosine receptors.
Pharmacological Reviews 2001;53:527–52.
10. Zeraati M, Mirnajaﬁ-Zadeh J, Fathollahi Y, Namvar S, Rezvani ME. Adenosine A1
and A2A receptors of hippocampal CA1 region have opposite effects on piriform
cortex kindled seizures in rats. Seizure 2006;15:41–8.
11. El Yacoubi M, Ledent C, Parmentier M, Dauust M, Costetin J, Vaugeois JM.
Absence of the adenosine A2A receptor or its chronic blockage decrease ethanol
withdrawal-induced seizures in mice. Neuropharmacology 2001;40:424–32.
12. El Yacoubi M, Ledent C, Parmentier M, Costetin J, Vaugeois JM. Adenosine A2A
receptor deﬁcient mice are partially resistant to limbic seizures. Naunyn-
Schmiedeberg’s Archves of Pharmacology 2009;380:223–32.
13. Lado FA, Moshe´ SL. How do seizures stop? Epilepsia 2008;49:1651–64.
14. Young D, Dragunow M. Status epilepticus may be caused by loss of adenosine
anticonvulsant mechanisms. Neuroscience 1994;58:245–61.
15. Shen HY, Li T, Boison D. A novel mouse model for sudden unexpected death in
epilepsy (SUDEP): roleof impairedadenosineclearance.Epilepsia2009;51:465–8.
16. Abu-Shaweesh JM. Activation of central adenosine A2A receptors enhances
superior laryngeal nerve stimulation-induced apnea in piglets via a GABAergic
pathway. Journal of Applied Physiology 2007;103:1205–11.
17. Boison D. Adenosine as a neuromodulator in neurological diseases. Current
Opinion in Pharmacology 2007;8:1–6.
18. Boison D. Adenosine augmentation therapies (AATs) for epilepsy: prospect of
cell and gene therapies. Epilepsy Research 2009;85:131–41.
